Effectively delivering a unique Hsp90 inhibitor using star polymers

ACS Medicinal Chemistry Letters

Volumn 4, Issue 10, 2013, Pages 915-920

  Kim, Seong Jong ^a   Ramsey, Deborah M ^a   Boyer, Cyrille ^b   Davis, Thomas P ^b   McAlpine, Shelli R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

cyclic peptides; drug delivery; drug peptide conjugation; Heat shock protein 90; hsp90; macrocycles; nanoparticles; polymers; star polymer

Indexed keywords

HEAT SHOCK PROTEIN 90 INHIBITOR; MACROGOL; NANOCARRIER; POLYMER; STAR POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CONFOCAL MICROSCOPY; DRUG RELEASE; HEAT SHOCK RESPONSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT SCATTERING; PH; POLYMERIZATION; PRIORITY JOURNAL;

EID: 84885442518     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml400082b     Document Type: Article

References (45)

1. Bohonowych, J. E.; Gopal, U.; Isaacs, J. S. Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls J. Oncol. 2010, 2010, 412-485
2. Jolly, C.; Morimoto, R. I. Role of the heat shock protein response and molecular chaperones in oncogenesis and cell death J. Natl. Cancer Inst. 2000, 92, 1564-1572
3. Neckers, L.; Ivy, S. P. Heat shock protein 90 Curr. Opin. Oncol. 2003, 15, 419-424
4. Neckers, L. Hsp90 inhbitors as novel cancer chemotherapeutic agents Trends Mol. Med. 2002, 8, S55-S61
5. Parsell, D. A.; Lindquist, S. The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins Annu. Rev. Genet. 1993, 27, 437-496
6. Parsell, D. A.; Taulien, J.; Lindquist, S. The role of heat-shock proteins in thermotolerance Philos. Trans. R. Soc. London, Ser. B 1993, 339, 279-285 dicussion, 285-286
7. Chiosis, G.; JHuezo, H.; Rosen, N.; Mimgaugh, E.; Whitesell, L.; Neckers, L. 17AAG: low target binding affinity and potent cell activity-finding an explanation Mol. Cancer Ther. 2003, 2, 123-129
8. Neckers, L. Heat shock protein 90: the cancer chaperone J. Biosci. 2007, 32, 517-530
9. Takayama, S.; Reed, J. C.; Homma, S. Heat-shock proteins as regulators of apoptosis Oncogene 2003, 22, 9041-9047
10. Kamal, A.; Thao, L.; Sensintaffar, J.; Zhang, L.; Boehm, M. F.; Fritz, L. C.; Burrows, F. J. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors Nature 2003, 425, 407-410
11. Clinical Trials. http://www.clinicaltrials.gov.
12. Neckers, L.; Workman, P. Hsp90 molecular chaperone inhibitors: Are we there yet? Clin. Cancer Res. 2012, 18, 64-76
13. Trepel, J.; Mollapour, M.; Giaccone, G.; Neckers, L. Targeting the dynamic HSP90 complex in cancer Nat. Rev. Cancer 2010, 10, 537-549
14. Beliakoff, J.; Whitesell, L. Hsp90: An emerging target for breast cancer therapy Anticancer Drugs 2004, 15, 651-662
15. Workman, P. Altered states: Selectively drugging the Hsp90 cancer chaperone Trends Mol. Med. 2004, 10, 47-51
16. Carroll, C. L.; Johnston, J. V. C.; Kekec, A.; Brown, J. D.; Parry, E.; Cajica, J.; Medina, I.; Cook, K. M.; Corral, R.; Pan, P.-S.; McAlpine, S. R. Synthesis and Cytotoxicity of Novel Sansalvamide A Derivatives Org. Lett. 2005, 7, 3481-3484
17. Otrubova, K.; Lushington, G. H.; Vander Velde, D.; McGuire, K. L.; McAlpine, S. R. A comprehensive study of Sansalvamide A derivatives and their structure-activity relationships against drug-resistant colon cancer cell lines J. Med. Chem. 2008, 51, 530-544
18. Pan, P. S.; Vasko, R. C.; Lapera, S. A.; Johnson, V. A.; Sellers, R. P.; Lin, C.-C.; Pan, C.-M.; Davis, M. R.; Ardi, V. C.; McAlpine, S. R. A comprehensive study of Sansalvamide A derivatives: their structure-activity relationships and their binding mode to Hsp90 Bioorg. Med. Chem 2009, 17, 5806-5825
19. Vasko, R. C.; Rodriguez, R. A.; Cunningham, C. N.; Ardi, V. C.; Agard, D. A.; McAlpine, S. R. Mechanistic studies of Sansalvamide A-Amide: an allosteric modulator of Hsp90 ACS Med. Chem. Lett. 2010, 1, 4-8
20. Alexander, L. D.; Partridge, J. R.; Agard, D. A.; McAlpine, S. R. A small molecule that preferentially binds the closed Hsp90 conformation Bioorg. Med. Chem. Lett 2011, 21, 7068-7071
21. Ardi, V. C.; Alexander, L. D.; Johnson, V. A.; McAlpine, S. R. Macrocycles that inhibit the binding between heat shock protein 90 and TPR-containing proteins ACS Chem. Biol. 2011, 6, 1357
22. Kunicki, J. B.; Petersen, M. N.; Alexander, L. D.; Ardi, V. C.; McConnell, J. R.; McAlpine, S. R. Synthesis and evaluation of biotinylated Sansalvamide A analogs and their modulation of Hsp90 Bioorg. Med. Chem. Lett. 2011, 21, 4716-4719
23. Davis, M. R.; Singh, E. K.; Wahyudi, H.; Alexander, L. D.; Kunicki, J.; Nazarova, L. A.; Fairweather, K. A.; Giltrap, A. M.; Jolliffe, K. A.; McAlpine, S. R. Synthesis of Sansalvamide A peptiodmimetics: trizaole, oxazole, thiazole, and psuedoproline containing compounds Tetrahedron 2012, 68, 1029-1051
24. Ramsey, D. M.; McConnell, J. R.; Alexander, L. D.; Tanaka, K. W.; Vera, C. M.; Mcalpine, S. R. A new Hsp90 inhibitor that exhibits a novel biological profile Bioorg. Med. Chem. Lett. 2012, 22, 3287-3290
25. Sellers, R. P.; Alexander, L. D.; Johnson, V. A.; Lin, C.-C.; Savage, J.; Corral, R.; Moss, J.; Slugocki, T. S.; Singh, E. K.; Davis, M. R.; Ravula, S.; Spicer, J. E.; Oelrich, J. L.; Thornquist, A.; Pan, C.-M.; McAlpine, S. R. A third generation of Sansalvamide A derivatives: Design and synthesis of Hsp90 Inhibitors Bioorg. Med. Chem. 2010, 18, 6822-6856
26. Wang, Y.; Grayson, S. M. Approachs for the preparation of non-linear amphiliic polymers adn their applications to drug delivery Adv. Drug Delivery Rev. 2012, 64, 852-865
27. Duan, S.; Cai, S.; Xie, Y.; Bagby, T. R.; Forrest, M. L. Synthesis and characterization of a multiarm poly(acrylic acid) star polymer for application in sustained delivery of cisplatin and a nitric oxide prodrug J. Polym. Sci., Part A: Polym. Chem. 2012, 50, 2715-2724
28. Lovell, J. F.; Huynh, E.; Macdonald, T. D.; Lin, Q.; Zheng, G. Biodegradable star polymers shine for cancer drug delivery Nanomedicine 2011, 6, 1155
29. Sulistio, A.; Lowenthal, J.; Blencowe, A.; Bongiovanni, M. N.; Ong, L.; Gras, S. L.; Zhang, X.; Qiao, G. G. Folic acid conjugated amino acid-based star polymers for active targeting of cancer cells Biomacromolecules 2011, 12, 3469-3477
30. Alconcel, S. N. S.; Baas, A. S.; Maynard, H. D. FDA-approved poly(ethylene glycol)-protein conjugate drugs Polym. Chem. 2011, 2, 1442-1448
31. Boyer, C.; Davis, T. P. One-pot synthesis and biofunctionalization of glycopolymers via RAFT polymerization and thiol-ene reactions Chem. Commun. 2009, 6029-6031
32. Boyer, C.; Bulmus, V.; Liu, J. Q.; Davis, T. P.; Stenzel, M. H.; Barner-Kowollik, C. Well-defined protein-polymer conjugates via in situ RAFT polymerization J. Am. Chem. Soc. 2007, 129, 7145-7154
33. Boyer, C.; Liu, J.; Bulmus, V.; Davis, T. P.; Barner-Kowollik, C.; Stenzel, M. H. Direct synthesis of well-defined heterotelechelic polymers for bioconjugations Macromolecules 2008, 41, 5641-5650
34. Liu, J.; Duong, H.; Whittaker, M. R.; Davis, T. P.; Boyer, C. Synthesis of functional core, star polymers via RAFT polymerization for drug delivery applications Macromol. Rapid Commun. 2012, 33, 760-767
35. Zastre, J.; Jackson, J.; Bajwa, M.; Liggins, R.; Iqbal, F.; Burt, H. Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by caco-2 cells using low molecular weight methoxypolyethylene glycol-block- polycaprolactone diblock copolymers Eur. J. Pharm Biopharm. 2002, 54, 299-309
36. Schroeder, A.; Heller, D. A.; Winslow, M. M.; Dahlman, J. E.; Pratt, G. W.; Langer, R.; Jacks, T.; Anderson, D. G. Nat. Rev. Cancer 2012, 12, 39-45
37. Banerjee, I.; Pangule, R. C.; Kane, R. S. Antifouling coatings: recent developments in the design of surfaces that prevent fouling by proteins, bacteria, and marine organisms Adv. Mater. 2011, 23, 690-718
38. Gabizon, A. A. Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet Clin. Cancer Res. 2001, 7, 223-225
39. Bjugstad, K. B.; Redmond, D. E., Jr.; Lampe, K. J.; Kern, D. S.; Sladek, J. R., Jr.; Mahoney, M. J. Biocompatibility of PEG-based hydrogels in primate brain Cell Transplant. 2008, 17, 409-415
40. Jackson, A. W.; Stakes, C.; Fulton, D. A. The formation of core cross-linked star polymer and nanogel assemblies facilitated by the formation of dynamic covalent imine bonds Polym. Chem. 2011, 2, 2500-2511
41. Jackson, A. W.; Fulton, D. A. The formation of core cross-linked star polymers containing cores cross-linked by dynamic covalent imine bonds Chem. Commun. 2010, 46, 6051-6053
42. Rodriguez, R. A.; Pan, P.-S.; Pan, C.-M.; Ravula, S.; Lapera, S. A.; Singh, E. K.; Styers, T. J.; Brown, J. D.; Cajica, J.; Parry, E.; Otrubova, K.; McAlpine, S. R. Synthesis of second generation Sansalvamide A derivatives: novel templates as potent anti-tumor agents J. Org. Chem. 2007, 72, 1980-2002
43. Kneipp, J.; Kneipp, H.; Wittig, B.; Kneipp, K. Following the dynamics of pH in endosomes of live cells with SERS nanosensors J. Phys. Chem. C 2010, 114, 7421-7426
44. Blankenberg, F. G.; Naumovski, L.; Tait, J. F.; Post, A. M.; Strauss, H. W. Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99mTc-radiolabeled annexin V J. Nucl. Med. 2001, 42, 309-316
45. Martin, S. J.; Reutelingsperger, C. P. M.; McGahon, A. J. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 Abl J. Exp. Med. 1995, 182, 1545-1556